Receive The Newest Study Notifications

Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients Laron Syndrome (aka Laron-type dwarfism) is a rare pediatric orphan disease...

SignalPath, a healthcare technology company reimagining the execution of clinical trials, announces the closing of their Series B funding round of $18 Million. The round was completed by existing investors with a total raise of capital to date of $35M. This funding...

HOUSTON, Nov. 5, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD...

80% of Methylated Patients and 75% of Unmethylated Patients Were Disease Progression-Free at 6 Months PLYMOUTH MEETING, Pa., Nov. 5, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today positive interim results from Inovio's Phase 2 study...

GAITHERSBURG, Md., Nov. 5, 2019 /PRNewswire/ -- Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer and autoimmune diseases, today announced that it has initiated a Phase 1/2 clinical trial...

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) for the...

VANCOUVER, Nov. 5, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application ("CTA") in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in...

MENLO PARK, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced the completion of the...

Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients Laron Syndrome (aka Laron-type dwarfism) is a rare pediatric orphan disease...

- Over 700 patients enrolled in the T2 Protect AD Study evaluating troriluzole in symptomatic treatment of mild-to-moderate Alzheimer's disease - Secondary and exploratory measures to assess if troriluzole can protect against, slow down, and potentially improve memory...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal Oncology at...

PRINCETON, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced the completion of enrollment of 471 subjects in...

-- RRx-001 is a small molecule immunotherapy targeting CD47 – SIRPα that repolarizes tumor associated macrophages -- LA JOLLA, Calif.--(BUSINESS WIRE)--EpicentRx, Inc., a clinical cancer immunotherapy company targeting both sides of the immune system to deliver cancer...

STOCKHOLM, Nov. 4, 2019 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 4th November 2019, that the first patient has been screened for the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac"). The screening took place...

This post was originally published on this site Xtalks Life Science Webinars Now, with both the FDA and the EMA showing support for eSource, it’s time for drug sponsors and CROs to begin to change the existing industry paradigm in order to implement these advancements...

Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal Oncology at Brigham and Women’s Hospital in...

On October 15th and 16th The Lupus Foundation of America helped to sponsor and participated in The Lupus 21st Century Conference, “Increasing Ancestral Diversity of SLE in Clinical Studies:  Overcoming the Barriers”. The ultimate goal of the meeting was to improve...

Mark Terry for Biospace writes: Even clinical trial announcements don’t slow down for Halloween. It was a typically busy week. Here’s a look. Y-mAbs Therapeutics provided a clinical update on its omburtamab for central nervous system (CNS) leptomeningeal metastases...

To harmonize eligibility criteria and radiographic disease assessments in clinical trials of adjuvant therapy for muscle-invasive bladder cancer (MIBC). National experts in bladder cancer clinical trial research, including medical and urologic oncologists,...

Trial opened for patient enrollment in the United States Independent Data Monitoring Committee recommends continuation of the trial as planned LYON, France and CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a...